JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-7.62 Cr | ₹-7.08 Cr | ₹-21 Cr | ₹-5.53 Cr | ₹-0.71 Cr |
What is the latest Cash Flow from Financing Activities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-7.62 Cr |
| Mar2024 | ₹-7.08 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-5.53 Cr |
| Mar2021 | ₹-0.71 Cr |
How is Cash Flow from Financing Activities of JENBURKT PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.62 Cr | Negative | |
| Mar2024 | ₹-7.08 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-5.53 Cr | Negative | |
| Mar2021 | ₹-0.71 Cr | - | |
Compare Cash Flow from Financing Activities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹451.4 Cr | -2.8% | -3.3% | 0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -2.8% |
-3.3% |
0.4% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses